NON-SMALL CELL SQUAMOUS LUNG CANCER
Clinical trials for NON-SMALL CELL SQUAMOUS LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL SQUAMOUS LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SMALL CELL SQUAMOUS LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human tests
Disease control Recruiting nowThis early-phase study tests a new drug called NXP900 in about 140 adults with advanced solid tumors (like lung, kidney, or mesothelioma) that have not responded to standard treatments. The goal is to find a safe dose and check for side effects, while also looking for signs that …
Matched conditions: NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Jun 16, 2026 22:03 UTC
-
Smart immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, called CAR T cells, that are specially designed to target and kill solid tumor cells while leaving healthy cells unharmed. It is for adults with certain advanced cancers, including lung, colon, pancreatic, ovari…
Matched conditions: NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC